Implants as drug delivery devices for the treatment of eye diseases
The treatment of diseases affecting the posterior segment of the eye is limited by the difficulty in transporting effective doses of drugs to the vitreous, retina, and choroid. Topically applied drugs are poorly absorbed due to the low permeability of the external ocular tissues and tearing. The blood-retina barrier limits drug diffusion from the systemic blood to the posterior segment, thus high doses of drug are needed to maintain therapeutic levels. In addition, systemic side effects are common. Intraocular injections could be an alternative, but the fast flowing blood supply in this region, associated with rapid clearance rates, causes drug concentration to quickly fall below therapeutic levels. To obtain therapeutic levels over longer time periods, polymeric sustained-drug release systems implanted within the vitreous are being studied for the treatment of vitreoretinal disorders. These systems are prepared using different kinds of biodegradable or non-biodegradable polymers. This review aims to demonstrate the main characteristics of these drug delivery implants and their potential for clinical application.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
2010
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502010000300024 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1984-82502010000300024 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1984-825020100003000242010-11-12Implants as drug delivery devices for the treatment of eye diseasesSilva,Gisele Rodrigues daFialho,Sílvia LigórioSiqueira,Rubens CamargoJorge,RodrigoCunha Júnior,Armando da Silva Implants/biodegradation Drugs/delivery systems Drugs/prolonged delivery systems Pharmaceutical technology The treatment of diseases affecting the posterior segment of the eye is limited by the difficulty in transporting effective doses of drugs to the vitreous, retina, and choroid. Topically applied drugs are poorly absorbed due to the low permeability of the external ocular tissues and tearing. The blood-retina barrier limits drug diffusion from the systemic blood to the posterior segment, thus high doses of drug are needed to maintain therapeutic levels. In addition, systemic side effects are common. Intraocular injections could be an alternative, but the fast flowing blood supply in this region, associated with rapid clearance rates, causes drug concentration to quickly fall below therapeutic levels. To obtain therapeutic levels over longer time periods, polymeric sustained-drug release systems implanted within the vitreous are being studied for the treatment of vitreoretinal disorders. These systems are prepared using different kinds of biodegradable or non-biodegradable polymers. This review aims to demonstrate the main characteristics of these drug delivery implants and their potential for clinical application.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.46 n.3 20102010-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502010000300024en10.1590/S1984-82502010000300024 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Silva,Gisele Rodrigues da Fialho,Sílvia Ligório Siqueira,Rubens Camargo Jorge,Rodrigo Cunha Júnior,Armando da Silva |
spellingShingle |
Silva,Gisele Rodrigues da Fialho,Sílvia Ligório Siqueira,Rubens Camargo Jorge,Rodrigo Cunha Júnior,Armando da Silva Implants as drug delivery devices for the treatment of eye diseases |
author_facet |
Silva,Gisele Rodrigues da Fialho,Sílvia Ligório Siqueira,Rubens Camargo Jorge,Rodrigo Cunha Júnior,Armando da Silva |
author_sort |
Silva,Gisele Rodrigues da |
title |
Implants as drug delivery devices for the treatment of eye diseases |
title_short |
Implants as drug delivery devices for the treatment of eye diseases |
title_full |
Implants as drug delivery devices for the treatment of eye diseases |
title_fullStr |
Implants as drug delivery devices for the treatment of eye diseases |
title_full_unstemmed |
Implants as drug delivery devices for the treatment of eye diseases |
title_sort |
implants as drug delivery devices for the treatment of eye diseases |
description |
The treatment of diseases affecting the posterior segment of the eye is limited by the difficulty in transporting effective doses of drugs to the vitreous, retina, and choroid. Topically applied drugs are poorly absorbed due to the low permeability of the external ocular tissues and tearing. The blood-retina barrier limits drug diffusion from the systemic blood to the posterior segment, thus high doses of drug are needed to maintain therapeutic levels. In addition, systemic side effects are common. Intraocular injections could be an alternative, but the fast flowing blood supply in this region, associated with rapid clearance rates, causes drug concentration to quickly fall below therapeutic levels. To obtain therapeutic levels over longer time periods, polymeric sustained-drug release systems implanted within the vitreous are being studied for the treatment of vitreoretinal disorders. These systems are prepared using different kinds of biodegradable or non-biodegradable polymers. This review aims to demonstrate the main characteristics of these drug delivery implants and their potential for clinical application. |
publisher |
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas |
publishDate |
2010 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502010000300024 |
work_keys_str_mv |
AT silvagiselerodriguesda implantsasdrugdeliverydevicesforthetreatmentofeyediseases AT fialhosilvialigorio implantsasdrugdeliverydevicesforthetreatmentofeyediseases AT siqueirarubenscamargo implantsasdrugdeliverydevicesforthetreatmentofeyediseases AT jorgerodrigo implantsasdrugdeliverydevicesforthetreatmentofeyediseases AT cunhajuniorarmandodasilva implantsasdrugdeliverydevicesforthetreatmentofeyediseases |
_version_ |
1756437725110599680 |